European Cardiac Resynchronisation Therapy Survey

NCT ID: NCT01185392

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2438 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-11-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The European CRT survey represents a joint initiative between two ESC associations; the Heart Failure Association and the European Heart Rhythm Association. The survey will be performed in collaboration with The Institute für Herzinfarktforschung in Ludwigshafen which will handle the data collection and data analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This European CRT Survey was initiated by the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of the ESC in order to describe current European practice and routines associated with CRT-P/CRT-D implantations based on sample of patients enrolled in 13 countries. The data collected following implantation provides information including clinical characteristics, diagnostic criteria, implantation routines and techniques, adverse experience, and assessment of adherence to guideline recommendations. The single follow-up visit at 1 year (9-15 months) will provide information regarding short-term clinical outcomes.

The primary objective of this Survey is to describe current European practice based on a broad sampling in 13 countries. The information collected will enable practice between centres and countries to be compared and permit benchmarking with national and international practice. The survey provides valuable quality assurance assessment for individual centres, permits limited economic analyses and broadly evaluates adherence to guideline recommendations.

The following 13 European countries contributed patients to the survey: Austria, Belgium, France, Germany, Ireland, Israel, Italy, the Netherlands, Norway, Spain, Sweden, Switzerland and UK. Two national coordinators, one each from the fields of heart failure and electrophysiology, were selected and given the responsibility to facilitate recruitment in their respective countries.

Follow the link for complete list of the members of the Scientific Committee and national coordinators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* eligible patients for CRT-P or CRT-D.

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role collaborator

Medtronic

INDUSTRY

Sponsor Role collaborator

Abbott Medical Devices

INDUSTRY

Sponsor Role collaborator

Biotronik SE & Co. KG

INDUSTRY

Sponsor Role collaborator

LivaNova

INDUSTRY

Sponsor Role collaborator

Roche Diagnostic Ltd.

INDUSTRY

Sponsor Role collaborator

Helse Stavanger HF

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kenneth Dickstein, MD, PHD

Role: STUDY_CHAIR

HFA of the ESC

Silvia Priori, MD, PHD

Role: STUDY_CHAIR

EHRA of the ESC

Angelo Auricchio, MD, PHD

Role: STUDY_DIRECTOR

EHRA of the ESC

Josep Brugada, MD, PHD

Role: STUDY_DIRECTOR

EHRA of the ESC

John Cleland, MD, PHD

Role: STUDY_DIRECTOR

HFA of the ESC

Geneviève Derumeaux, MD, PHD

Role: STUDY_DIRECTOR

EAE of the ESC

Daniel Gras, MD, PHD

Role: STUDY_DIRECTOR

EHRA of the ESC

Michel Komajda, MD, PHD

Role: STUDY_DIRECTOR

HFA of the ESC

Cecilia Linde, MD, PHD

Role: STUDY_DIRECTOR

EHRA of the ESC

John Morgan, MD, PHD

Role: STUDY_DIRECTOR

EHRA of the ESC

Dirk J van Veldhuisen, MD, PHD

Role: STUDY_DIRECTOR

HFA of the ESC

Anselm Gitt, MD

Role: STUDY_DIRECTOR

The Institut für Herzinfarktforschung in Ludwigshafen, Germany

Nigussie Bogale, MD

Role: STUDY_DIRECTOR

Stavanger University Hospital and University of Bergen, Norway

References

Explore related publications, articles, or registry entries linked to this study.

CRT Survey Scientific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail. 2009 Mar;11(3):326-30. doi: 10.1093/eurjhf/hfp030.

Reference Type BACKGROUND
PMID: 19228801 (View on PubMed)

Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators. The European cardiac resynchronization therapy survey. Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31.

Reference Type RESULT
PMID: 19723694 (View on PubMed)

Bogale N, Priori S, Cleland JG, Brugada J, Linde C, Auricchio A, van Veldhuisen DJ, Limbourg T, Gitt A, Gras D, Stellbrink C, Gasparini M, Metra M, Derumeaux G, Gadler F, Buga L, Dickstein K; Scientific Committee, National Coordinators, and Investigators. The European CRT Survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail. 2012 Jan;14(1):61-73. doi: 10.1093/eurjhf/hfr158.

Reference Type DERIVED
PMID: 22179034 (View on PubMed)

Bogale N, Witte K, Priori S, Cleland J, Auricchio A, Gadler F, Gitt A, Limbourg T, Linde C, Dickstein K; Scientific Committee, National coordinators and the investigators. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail. 2011 Sep;13(9):974-83. doi: 10.1093/eurjhf/hfr085. Epub 2011 Jul 19.

Reference Type DERIVED
PMID: 21771823 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.crt-survey.org

Synopsis of the Survey, list of participating countries and members of the Scientific Committee and national coordinators

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CRT Survey

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.